NEW YORK (GenomeWeb) – Belgian molecular diagnostics firm Biocartis today reported that its total revenues for the first half of 2018 jumped 83 percent year over year, driven by a rise in cartridge consumption and collaboration revenue.

For the six months ended June 30, Biocartis' total revenues soared to €12.7 million ($14.8 million) from €7.0 million in 2017.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.